# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-24-090850
Filing Date
2024-10-25
Accepted
2024-10-25 17:01:32
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | ea0217586-02.htm | DEFA14A | 34529
2 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1547288
3 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 673535
| Complete submission text file | 0001213900-24-090850.txt |  | 3095102

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 241397756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)